Fludeoxyglucose f-18

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

3189 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Prostatic neoplasms	D011471	—	C61	53	81	37	10	111	272
Neoplasms	D009369	—	C80	88	50	4	5	126	260
Alzheimer disease	D000544	EFO_0000249	F03	73	57	23	9	91	243
Breast neoplasms	D001943	EFO_0003869	C50	50	53	7	6	115	225
Non-small-cell lung carcinoma	D002289	—	—	27	45	7	1	76	148
Lung neoplasms	D008175	—	C34.90	26	32	9	2	82	143
Healthy volunteers/patients	—	—	—	65	11	2	2	20	98
Brain neoplasms	D001932	EFO_0003833	C71	25	21	4	2	41	89
Parkinson disease	D010300	EFO_0002508	G20	24	19	6	1	36	81
Neoplasm metastasis	D009362	EFO_0009708	—	12	13	3	1	37	66

Show 87 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Head and neck neoplasms	D006258	—	—	19	18	5	—	58	95
Lymphoma	D008223	—	C85.9	13	24	12	—	44	86
Cognitive dysfunction	D060825	—	G31.84	13	24	7	—	44	86
Glioma	D005910	EFO_0000520	—	19	13	3	—	33	66
Squamous cell carcinoma of head and neck	D000077195	—	—	23	21	3	—	22	62
Pancreatic neoplasms	D010190	EFO_0003860	C25	18	9	1	—	26	50
Hepatocellular carcinoma	D006528	—	C22.0	9	11	1	—	28	48
Colorectal neoplasms	D015179	—	—	10	10	2	—	27	45
Liver neoplasms	D008113	EFO_1001513	C22.0	6	11	2	—	28	45
Non-hodgkin lymphoma	D008228	—	C85.9	9	14	1	—	20	43

Show 104 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Glioblastoma	D005909	EFO_0000515	—	24	19	—	—	25	62
Melanoma	D008545	—	—	9	13	—	—	28	50
Carcinoma	D002277	—	C80.0	10	6	—	—	21	35
Large b-cell lymphoma diffuse	D016403	—	C83.3	9	10	—	—	17	35
Rectal neoplasms	D012004	—	—	4	8	—	—	22	33
Hypoxia	D000860	—	R09.02	1	6	—	—	15	22
Tauopathies	D024801	—	—	5	4	—	—	10	19
Astrocytoma	D001254	EFO_0000271	—	7	4	—	—	9	18
Pheochromocytoma	D010673	—	—	5	4	—	—	9	18
Paraganglioma	D010235	—	—	3	3	—	—	10	16

Show 187 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Progressive supranuclear palsy	D013494	EFO_0002512	G23.1	12	—	—	—	7	19
Meningioma	D008579	EFO_0003098	D32.9	4	—	—	—	5	9
Hematologic neoplasms	D019337	—	—	2	—	—	—	7	9
Pneumonia	D011014	EFO_0003106	J18	4	—	—	—	4	8
Huntington disease	D006816	Orphanet_399	G10	4	—	—	—	4	8
Sclerosis	D012598	—	—	3	—	—	—	4	7
Post-traumatic stress disorders	D013313	EFO_0001358	F43.1	1	—	—	—	6	7
T-cell lymphoma peripheral	D016411	—	—	3	—	—	—	4	7
Extranodal nk-t-cell lymphoma	D054391	—	C86.0	1	—	—	—	6	7
T-cell lymphoma	D016399	—	—	3	—	—	—	4	7

Show 113 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Infections	D007239	EFO_0000544	—	—	—	—	—	13	13
Metabolic syndrome	D024821	EFO_0000195	E88.810	—	—	—	—	6	6
Thrombosis	D013927	—	—	—	—	—	—	6	6
Vasculitis	D014657	EFO_0006803	M31	—	—	—	—	5	5
Gastrointestinal diseases	D005767	—	—	—	—	—	—	5	5
Ischemic stroke	D000083242	—	—	—	—	—	—	5	5
Fever	D005334	—	R50.9	—	—	—	—	4	4
Psychotic disorders	D011618	—	F20.81	—	—	—	—	4	4
Digestive system diseases	D004066	EFO_0000405	K92.9	—	—	—	—	4	4
Disease progression	D018450	—	—	—	—	—	—	4	4

Show 335 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	—
INN	—
Description	—
Classification	Unknown
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—